NVNO (STOCKS)
enVVeno Medical Corporation Common Stock
$11.200000
+0.140000 (+1.27%)
Prev close: $11.060000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Robert Andrew Berman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7.24M
- Employees
- 37
- P/E (TTM)
- -0.33
- P/B (TTM)
- 0.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-8.05 | $-10.71 | +2.6600 | +24.84% |
|
Jun 2025 (Q2)
|
$-11.55 | $-10.00 | -1.5540 | -15.55% |
|
Mar 2025 (Q1)
|
$-7.70 | $-12.14 | +4.4380 | +36.56% |
|
Dec 2024 (Q4)
|
$-10.50 | $-12.50 | +1.9950 | +15.97% |
Financial Statements
| Nonoperating Income/Loss | $1.43M |
| Selling, General, and Administrative Expenses | $10.92M |
| Depreciation and Amortization | $136.00K |
| Research and Development | $9.98M |
| Operating Income/Loss | -$20.90M |
| Income/Loss From Continuing Operations After Tax | -$19.47M |
| Income/Loss From Continuing Operations Before Tax | -$19.47M |
| Net Income/Loss | -$19.47M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$19.47M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.47M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$33.06 |
| Diluted Earnings Per Share | -$33.06 |
| Basic Average Shares | 589,000 |
| Diluted Average Shares | 589,000 |
| Assets | $29.56M |
| Current Assets | $28.83M |
| Noncurrent Assets | $736.00K |
| Fixed Assets | $51.00K |
| Other Non-current Assets | $685.00K |
| Liabilities | $2.43M |
| Current Liabilities | $2.12M |
| Accounts Payable | $358.00K |
| Other Current Liabilities | $1.76M |
| Noncurrent Liabilities | $310.00K |
| Equity | $27.13M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $27.13M |
| Liabilities And Equity | $29.56M |
| Net Cash Flow From Operating Activities | -$15.57M |
| Net Cash Flow From Operating Activities, Continuing | -$15.57M |
| Net Cash Flow From Investing Activities | $15.86M |
| Net Cash Flow From Investing Activities, Continuing | $15.86M |
| Net Cash Flow From Financing Activities | $1.02M |
| Net Cash Flow From Financing Activities, Continuing | $1.02M |
| Net Cash Flow | $1.31M |
| Net Cash Flow, Continuing | $1.31M |
| Comprehensive Income/Loss | -$19.47M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$19.47M |
| Other Comprehensive Income/Loss | $0.00 |